Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys add-on to nucleos(t)ide analogue therapy in chronic HBeAg-negative hepatitis B
2011-002812-10Phase 2Completed
- Sponsor
- University Medical Center Mainz
- Start
- Nov 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of interferon alfa in Chronic Hepatitis B (CHB) (2 arms), sponsored by University Medical Center Mainz. Primary endpoint: Objective response at week 48. Started Nov 2011; status: completed.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2011-002812-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002812-10.